Integrated care pathways for airway diseases (AIRWAYS-ICPs)

被引：141

作者：

Bousquet, J. ^{[1
,2
,3
,4
,5
,6
,7
]}

Addis, A. ^{[6
,8
]}

Adcock, I. ^{[9
,10
]}

Agache, I. ^{[3
,11
,12
]}

Agusti, A. ^{[13
,14
]}

Alonso, A. ^{[15
]}

Annesi-Maesano, I. ^{[3
]}

Anto, J. M. ^{[16
]}

Bachert, C. ^{[3
,17
,18
]}

Baena-Cagnani, C. E. ^{[3
,19
]}

Bai, C. ^{[20
]}

Baigenzhin, A. ^{[21
]}

Barbara, C. ^{[6
,22
]}

Barnes, P. J. ^{[9
,10
]}

Bateman, E. D. ^{[3
,23
]}

Beck, L. ^{[24
]}

Bedbrook, A. ^{[2
,3
]}

Bel, E. H. ^{[25
]}

Benezet, O. ^{[2
]}

Bennoor, K. S. ^{[3
,26
,27
]}

Benson, M. ^{[28
]}

Bernabeu-Wittel, M. ^{[29
,30
]}

Bewick, M. ^{[31
]}

Bindslev-Jensen, C. ^{[3
,32
,33
]}

Blain, H. ^{[1
,2
,7
]}

Blasi, F. ^{[34
]}

Bonini, M. ^{[3
,35
]}

Bonini, S. ^{[3
,36
,37
]}

Boulet, L. P. ^{[3
,38
]}

Bourdin, A. ^{[1
,2
,7
,39
]}

Bourret, R. ^{[1
,2
]}

Bousquet, P. J. ^{[3
]}

Brightling, C. E. ^{[40
]}

Briggs, A. ^{[41
]}

Brozek, J. ^{[3
,42
,43
]}

Buhl, R. ^{[44
]}

Bush, A. ^{[3
,45
,46
]}

Caimmi, D. ^{[1
,2
]}

Calderon, M. ^{[47
,48
]}

Calverley, P. ^{[49
,50
]}

Camargos, P. A. ^{[3
,51
]}

Camuzat, T. ^{[2
]}

Canonica, G. W. ^{[3
,52
]}

Carlsen, K. H. ^{[3
,53
,54
]}

Casale, T. B. ^{[3
]}

Cazzola, M. ^{[55
]}

Sarabia, A. M. Cepeda ^{[3
,56
,57
]}

Cesario, A. ^{[58
]}

Chen, Y. Z. ^{[59
]}

Chkhartishvili, E. ^{[60
]}

机构：

[1] Univ Hosp Montpellier, Montpellier, France

[2] MACVIA LR, Fighting Chron Dis Hlth Ageing, Region Languedoc Roussil, France

[3] ARIA, Montpellier, France

[4] European Acad Allergy & Clin Immunol, Montpellier, France

[5] European Innovat Partnership Act & Hlth Ageing, Montpellier, France

[6] European Innovat Partnership Act & Hlth Ageing, Commitment Act B3, Montpellier, France

[7] Univ Montpellier I, Montpellier, France

[8] European Innovat Partnership Act & Hlth Ageing, Regione Emilia Romagna, Italy

[9] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England

[10] Royal Brompton & Harefield NIHR Biomed Res Unit, London, England

[11] Romanian Alliance Chron Resp Dis, Brasov, Romania

[12] Transylvania Univ, Fac Med, Brasov, Romania

[13] Univ Barcelona, Hosp Clin Barcelona, IDIBAPS, Thorax Inst, Barcelona, Spain

[14] CIBER Enfermedades Resp, Barcelona, Spain

[15] Hosp Clin Barcelona, FCRB, Barcelona, Spain

[16] Univ Pompeu Fabra, CIBER Epidemiol & Salud Publ CIBERESP, IMIM Hosp del Mar Med Res Inst, Ctr Res Environm Epidemiol CREAL, Barcelona, Spain

[17] Ghent Univ Hosp, Dept Resp Med, Ghent, Belgium

[18] Ghent Univ Hosp, ENT Dept, Ghent, Belgium

[19] Catholic Univ, Fac Med, Res Ctr Resp Med CIMER, Cordoba, Argentina

[20] Chinese Med Assoc, Shanghai Resp Res Inst, Shanghai, Peoples R China

[21] EuroAsian Resp Soc, Astana City, Kazakhstan

[22] Portuguese Natl Programme Resp Dis, PNDR, Lisbon, Portugal

[23] Univ Cape Town, Fac Hlth Sci, Dept Med, Div Pulmonol, ZA-7700 Rondebosch, South Africa

[24] Hlth Innovat Ctr Southern Denmark, Region Southern Denmark, Denmark

[25] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands

[26] Bangladesh Lung Fdn, Dhaka, Bangladesh

[27] Natl Inst Dis Chest & Hosp, Dhaka, Bangladesh

[28] Linkoping Univ, Dept Clin & Expt Sci, Ctr Individualised Med, Linkoping, Sweden

[29] European Innovat Partnership Act & Hlthy Ageing, Aura Andalucia, Spain

[30] Andalusian Healthcare Serv, Andalucia, Spain

[31] NHS England, London, England

[32] Odense Univ Hosp, Odense Res Ctr Anaphylaxis, Dept Dermatol, DK-5000 Odense, Denmark

[33] Odense Univ Hosp, Odense Res Ctr Anaphylaxis, Allergy Ctr, DK-5000 Odense, Denmark

[34] Univ Milan, IRCCS Ca Granda, European Resp Soc, Milan, Italy

[35] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, I-00185 Rome, Italy

[36] Univ Naples 2, Naples, Italy

[37] Italian Natl Res Council, Inst Translat Med, Naples, Italy

[38] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada

[39] INSERM, U1046, Montpellier, France

[40] Glenfield Hosp, Leicester Resp Biomed Res Unit, Natl Inst Hlth Res, Leicester, Leics, England

[41] Univ Glasgow, Inst Hlth & Wellbeing, Hlth Econ & Hlth Technol Assessment, Glasgow, Lanark, Scotland

[42] McMaster Univ, Dept Clin Epidemiol, Hamilton, ON, Canada

[43] McMaster Univ, Dept Biostat & Med, Hamilton, ON, Canada

[44] Mainz Univ Hosp, Med Ctr, Dept Pulm, Mainz, Germany

[45] Univ London Imperial Coll Sci Technol & Med, Dept Paediat Resp Med, Royal Brompton Hosp, London, England

[46] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England

[47] Univ Costa Rica, San Jose, Costa Rica

[48] Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, Sect Allergy & Clin Immunol, London, England

[49] Univ Liverpool, Inst Ageing & Chron Dis, Liverpool L69 3BX, Merseyside, England

[50] Aintree Univ Hosp NHS Fdn Trust, Liverpool L9 7AL, Merseyside, England

来源：

EUROPEAN RESPIRATORY JOURNAL | 2014年 / 44卷 / 02期

关键词：

OBSTRUCTIVE PULMONARY-DISEASE; CHRONIC RESPIRATORY-DISEASES; ASTHMA; HEALTH; PROGRAM; PERFORMANCE; SIMULATION; MANAGEMENT; DIAGNOSIS; QUALITY;

D O I：

10.1183/09031936.00014614

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

The objective of Integrated Care Pathways for Airway Diseases (AIRWAYS-ICPs) is to launch a collaboration to develop multi-sectoral care pathways for chronic respiratory diseases in European countries and regions. AIRWAYS-ICPs has strategic relevance to the European Union Health Strategy and will add value to existing public health knowledge by: 1) proposing a common framework of care pathways for chronic respiratory diseases, which will facilitate comparability and trans-national initiatives; 2) informing cost-effective policy development, strengthening in particular those on smoking and environmental exposure; 3) aiding risk stratification in chronic disease patients, using a common strategy; 4) having a significant impact on the health of citizens in the short term (reduction of morbidity, improvement of education in children and of work in adults) and in the long-term (healthy ageing); 5) proposing a common simulation tool to assist physicians; and 6) ultimately reducing the healthcare burden (emergency visits, avoidable hospitalisations, disability and costs) while improving quality of life. In the longer term, the incidence of disease may be reduced by innovative prevention strategies. AIRWAYS-ICPs was initiated by Area 5 of the Action Plan B3 of the European Innovation Partnership on Active and Healthy Ageing. All stakeholders are involved (health and social care, patients, and policy makers).

引用

页码：304 / 323

页数：20

共 68 条

[1]

[Anonymous], 2010, PACK ESS NCD INT PRI

[2]

[Anonymous], 2013, QOF CLIN INDICATORS

[3]

[Anonymous], 2007, 3 US DEP HLTH HUM SE

[4]

[Anonymous], 2010, CHRON OBSTR PULM DIS

[5] Coronary heart disease: A disorder of growth [J].

Barker, DJP .

HORMONE RESEARCH, 2003, 59 :35-41

[6] FETAL AND PLACENTAL SIZE AND RISK OF HYPERTENSION IN ADULT LIFE [J].

BARKER, DJP ;

BULL, AR ;

OSMOND, C ;

SIMMONDS, SJ .

BRITISH MEDICAL JOURNAL, 1990, 301 (6746) :259-262

[7] Global strategy for asthma management and prevention: GINA executive summary [J].

Bateman, E. D. ;

Hurd, S. S. ;

Barnes, P. J. ;

Bousquet, J. ;

Drazen, J. M. ;

FitzGerald, M. ;

Gibson, P. ;

Ohta, K. ;

O'Byrne, P. ;

Pedersen, S. E. ;

Pizzichini, E. ;

Sullivan, S. D. ;

Wenzel, S. E. ;

Zar, H. J. .

EUROPEAN RESPIRATORY JOURNAL, 2008, 31 (01) :143-178

[8] Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI) [J].

Bel, Elisabeth H. ;

Sousa, Ana ;

Fleming, Louise ;

Bush, Andrew ;

Chung, K. Fan ;

Versnel, Jennifer ;

Wagener, Ariane H. ;

Wagers, Scott S. ;

Sterk, Peter J. ;

Compton, Chris H. .

THORAX, 2011, 66 (10) :910-917

[9]

Bolton Patrick, 2011, World Hosp Health Serv, V47, P31

[10]

Borycki Elizabeth M, 2009, Healthc Q, V12 Spec No Patient, P90

← 1 2 3 4 5 6 7 →